These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma. Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574 [TBL] [Abstract][Full Text] [Related]
23. Herbal medicine use, Epstein-Barr virus, and risk of nasopharyngeal carcinoma. Hildesheim A; West S; DeVeyra E; De Guzman MF; Jurado A; Jones C; Imai J; Hinuma Y Cancer Res; 1992 Jun; 52(11):3048-51. PubMed ID: 1317256 [TBL] [Abstract][Full Text] [Related]
24. Loss of heterozygosity and its correlation with clinical outcome and Epstein-Barr virus infection in nasopharyngeal carcinoma. Shao JY; Huang XM; Yu XJ; Huang LX; Wu QL; Xia JC; Wang HY; Feng QS; Ren ZF; Ernberg I; Hu LF; Zeng YX Anticancer Res; 2001; 21(4B):3021-9. PubMed ID: 11712805 [TBL] [Abstract][Full Text] [Related]
25. The interplay of host genetic factors and Epstein-Barr virus in the development of nasopharyngeal carcinoma. Lung ML; Cheung AK; Ko JM; Lung HL; Cheng Y; Dai W Chin J Cancer; 2014 Nov; 33(11):556-68. PubMed ID: 25367335 [TBL] [Abstract][Full Text] [Related]
26. Oncogenic role of Epstein-Barr virus-encoded small RNAs (EBERs) in nasopharyngeal carcinoma. Yoshizaki T; Endo K; Ren Q; Wakisaka N; Murono S; Kondo S; Sato H; Furukawa M Auris Nasus Larynx; 2007 Mar; 34(1):73-8. PubMed ID: 17129696 [TBL] [Abstract][Full Text] [Related]
27. Detection of transcripts initiated from two viral promoters (Cp and Wp) in Epstein-Barr virus-infected nasopharyngeal carcinoma cells and biopsies. Chang Y; Sheen TS; Lu J; Huang YT; Chen JY; Yang CS; Tsai CH Lab Invest; 1998 Jun; 78(6):715-26. PubMed ID: 9645762 [TBL] [Abstract][Full Text] [Related]
28. Distribution of Epstein-Barr virus genotypes in throat washings, sera, peripheral blood lymphocytes and in EBV positive tumor biopsies from Slovenian patients with nasopharyngeal carcinoma. Klemenc P; Marin J; Soba E; Gale N; Koren S; Strojan P J Med Virol; 2006 Aug; 78(8):1083-90. PubMed ID: 16789009 [TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr Virus-Based Nasopharyngeal Carcinoma (NPC) Risk Prediction Scores Are Elevated in NPC Multiplex Family Members in Taiwan. Lee MH; Huang YH; Coghill AE; Liu Z; Yu KJ; Hsu WL; Chien YC; Wang CP; Chen TC; Chen CJ; Hildesheim A J Infect Dis; 2021 Feb; 223(3):441-444. PubMed ID: 32614957 [TBL] [Abstract][Full Text] [Related]
30. Reconstitution of nasopharyngeal carcinoma-type EBV infection induces tumorigenicity. Seto E; Ooka T; Middeldorp J; Takada K Cancer Res; 2008 Feb; 68(4):1030-6. PubMed ID: 18281477 [TBL] [Abstract][Full Text] [Related]
31. Prevalence of the Taiwan variant of the Epstein-Barr virus in nasopharyngeal carcinoma patients and normal individuals. Shu CH; Tu TY Zhonghua Yi Xue Za Zhi (Taipei); 2000 Apr; 63(4):288-93. PubMed ID: 10820907 [TBL] [Abstract][Full Text] [Related]
32. Frequent chromosome 9p losses in histologically normal nasopharyngeal epithelia from southern Chinese. Chan AS; To KF; Lo KW; Ding M; Li X; Johnson P; Huang DP Int J Cancer; 2002 Nov; 102(3):300-3. PubMed ID: 12397655 [TBL] [Abstract][Full Text] [Related]
33. Genetic susceptibility to the endemic form of NPC. Bei JX; Zuo XY; Liu WS; Guo YM; Zeng YX Chin Clin Oncol; 2016 Apr; 5(2):15. PubMed ID: 27121875 [TBL] [Abstract][Full Text] [Related]
34. Inhibition of nasopharyngeal carcinoma growth by RTA-expressing baculovirus vectors containing oriP. Wang L; Shan L; Lo KW; Yin J; Zhang Y; Sun R; Zhong J J Gene Med; 2008 Oct; 10(10):1124-33. PubMed ID: 18642396 [TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus infection of sinonasal lymphoepithelial carcinoma in Guangzhou. Zong Y; Liu K; Zhong B; Chen G; Wu W Chin Med J (Engl); 2001 Feb; 114(2):132-6. PubMed ID: 11780191 [TBL] [Abstract][Full Text] [Related]
36. Nasopharyngeal carcinoma in Indonesia has a low prevalence of the 30-base pair deletion of Epstein-Barr virus latent membrane protein 1. Nurhantari Y; Emoto N; Rahayu P; Matsuo M Southeast Asian J Trop Med Public Health; 2003 Mar; 34(1):98-105. PubMed ID: 12971521 [TBL] [Abstract][Full Text] [Related]
37. HLA Class II alleles and the presence of circulating Epstein-Barr virus DNA in Greek patients with nasopharyngeal carcinoma. Karanikiotis C; Daniilidis M; Karyotis N; Bakogiannis C; Economopoulos T; Murray S; Papamichael D; Samantas E; Nikolaou A; Skoura L; Tselis N; Zamboglou N; Fountzilas G Strahlenther Onkol; 2008 Jun; 184(6):325-31. PubMed ID: 18535809 [TBL] [Abstract][Full Text] [Related]
38. Translational genomics of nasopharyngeal cancer. Tsang CM; Lui VWY; Bruce JP; Pugh TJ; Lo KW Semin Cancer Biol; 2020 Apr; 61():84-100. PubMed ID: 31521748 [TBL] [Abstract][Full Text] [Related]
39. Cyclin D1 overexpression supports stable EBV infection in nasopharyngeal epithelial cells. Tsang CM; Yip YL; Lo KW; Deng W; To KF; Hau PM; Lau VM; Takada K; Lui VW; Lung ML; Chen H; Zeng M; Middeldorp JM; Cheung AL; Tsao SW Proc Natl Acad Sci U S A; 2012 Dec; 109(50):E3473-82. PubMed ID: 23161911 [TBL] [Abstract][Full Text] [Related]
40. Early detection of nasopharyngeal carcinoma by plasma Epstein-Barr virus DNA analysis in a surveillance program. Chan KC; Hung EC; Woo JK; Chan PK; Leung SF; Lai FP; Cheng AS; Yeung SW; Chan YW; Tsui TK; Kwok JS; King AD; Chan AT; van Hasselt AC; Lo YM Cancer; 2013 May; 119(10):1838-44. PubMed ID: 23436393 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]